Safety and Efficacy of Intravenous Cladribine in Multiple Sclerosis Patients

被引：0
|
作者：
Alchaki, Abdul Rahman [1 ]
Anadani, Nidhiben [2 ]
Cook, Stuart [3 ]
机构：
[1] Rutgers State Univ, Clifton, NJ USA
[2] Rutgers State Univ, Newark, NJ USA
[3] Rutgers State Univ, Newark, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P039
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [21] INTEGRATED SAFETY ANALYSIS; CLADRIBINE IN MULTIPLE SCLEROSIS (MS)
    Cook, Stuart
    Leist, Thomas
    Comi, Giancarlo
    Montalban, Xavier
    Sylvester, Elke
    Hicking, Christine
    Dangond, Fernando
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A49 - A49
  • [22] Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients
    Khorshid, Ola
    Namour, Alfred Elias
    El-Gammal, Mosaad M.
    Mahmoud, Tarek Yakout
    Fortpied, Catherine
    Abdel-Malek, Raafat
    Ramadan, Safaa
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
  • [23] Safety and efficacy of IV cladribine versus alemtuzumab in aggressive multiple sclerosis: a retrospective cohort study
    Bose, Gauruv
    Freedman, Mark
    Rush, Carolina
    Bowman, Marjorie
    Atkins, Harold
    NEUROLOGY, 2018, 90
  • [24] Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
    Moser, Tobias
    Ziemssen, Tjalf
    Sellner, Johann
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (15-16) : 365 - 372
  • [25] Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
    Savic, Radojka M.
    Novakovic, Ana M.
    Ekblom, Marianne
    Munafo, Alain
    Karlsson, Mats O.
    CLINICAL PHARMACOKINETICS, 2017, 56 (10) : 1245 - 1253
  • [26] Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
    Radojka M. Savic
    Ana M. Novakovic
    Marianne Ekblom
    Alain Munafo
    Mats O. Karlsson
    Clinical Pharmacokinetics, 2017, 56 : 1245 - 1253
  • [27] Cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis of safety from the multiple sclerosis clinical development program
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Sylvester, E.
    Hicking, C.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 305 - 306
  • [28] Safety and tolerability of subcutaneous cladribine therapy in progressive multiple sclerosis
    Selby, R
    Brandwein, J
    O'Connor, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 25 (04) : 295 - 299
  • [29] Analysis of Evusheld safety and efficacy in multiple sclerosis patients
    Liu, Emilie N.
    Real, Marcos
    Yang, Jennifer H.
    Fair, Ashley
    Whitmire, Natalie
    Perez, Allyssa
    Wilder, Carolyn
    Rosengren, Shauna
    Kinkel, Revere P.
    Graves, Jennifer S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 88
  • [30] Mitoxantrone efficacy and safety in a cohort of multiple sclerosis patients
    Martinelli Boneschi, F.
    Rodegher, M. E.
    Moiola, L.
    Radaelli, M.
    Rocca, M.
    Esposito, F.
    Torrisi, F.
    Bellini, A.
    Martinelli, V.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2006, 253 : 81 - 81
12345